Majid, Reymelie D.

HRN: 08-69-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFTRIAXONE 1G (VIAL)
05/11/2023
05/17/2023
IV
2g
OD
T/c Acute Cholecystitis
Waiting Final Action 
05/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2023
05/18/2023
IV
500 Mg
Q8h
Acute Cholecystitis
Waiting Final Action 
05/17/2023
METRONIDAZOLE 500MG (TAB)
05/17/2023
05/18/2023
PO
500mg
TID
Acute Cholecystitis
Waiting Final Action 
05/27/2023
CEFAZOLIN 1GM (VIAL)
05/27/2023
06/03/2023
IV
2grama
Single Dose
Cholecystitis, Choledocholithiasis
Waiting Final Action 
05/30/2023
CEFAZOLIN 1GM (VIAL)
05/30/2023
06/06/2023
IVTT
1gram
Q8hrs
S/P Open Cholecystectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: